GGrantIndex
← Leaderboards

Nadia R Roan

University Of California, San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$13,619,124
Attributed
$17,983,297
Total exposure
15
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY2013–25
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,670,434 · 16

By mechanism

R01$11,515,338 · 5
P01$4,297,149 · 3
R21$2,438,638 · 5
R56$794,045 · 1
R00$492,559 · 1
K99$132,705 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsViralHiv InfectionsImmunePhenotypeTissuesGenetic TranscriptionResponseInfectionAntiretroviral TherapyVirusCytokineCd4 Positive T LymphocytesPersonsProteinsBloodSignal TransductionMediatingSingle-Cell Rna SequencingIn VivoExhibitsTechnologyDesignFemale

Grant awards (38)

Assessing the mechanisms underlying female sex-predominance in Long COVID$913,012
R01 · FY2025 · AI
Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV$891,217
R01 · FY2025 · AI · contact PI
Multiomics characterization, induction, and elimination of the HIV gut reservoir$724,238
R01 · FY2025 · DK · contact PI
Targeting CD127-expressing tissue reservoir cells as a strategy for HIV cure$252,348
R21 · FY2025 · AI · contact PI
Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV$915,998
R01 · FY2024 · AI · contact PI
STudy of Acute HIV for investiGating Eradication Strategies (STAGES)$794,045
R56 · FY2024 · AI
Multiomics characterization, induction, and elimination of the HIV gut reservoir$695,727
R01 · FY2024 · DK · contact PI
Targeting CD127-expressing tissue reservoir cells as a strategy for HIV cure$250,791
R21 · FY2024 · AI · contact PI
Multiomics characterization, induction, and elimination of the HIV gut reservoir$725,170
R01 · FY2023 · DK · contact PI
Reservoir features associated with time-to-rebound during analytical treatment interruption$395,121
P01 · FY2023 · AI · contact PI
Characterizing ART-free NK cell-mediated control of HIV infection in people living with HIV$236,250
R21 · FY2023 · AI · contact PI
Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir$231,225
R21 · FY2023 · AI
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies$843,541
R01 · FY2022 · AI · contact PI
Multiomics characterization, induction, and elimination of the HIV gut reservoir$792,352
R01 · FY2022 · DK · contact PI
Reservoir features associated with time-to-rebound during analytical treatment interruption$500,149
P01 · FY2022 · AI · contact PI
Single-cell Analysis of Glycomic and Proteomic Features of the HIV Reservoir$298,380
R21 · FY2022 · AI
Characterizing ART-free NK cell-mediated control of HIV infection in people living with HIV$283,500
R21 · FY2022 · AI · contact PI
Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption$1,687,137
P01 · FY2021 · AI · contact PI
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies$1,560,753
R01 · FY2021 · AI · contact PI
Project 1: Using CyTOF to identify phenotypic and functional biomarkers predicting time to HIV rebound after treatment interruption$320,189
P01 · FY2021 · AI · contact PI
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies$855,438
R01 · FY2020 · AI · contact PI
Elucidating the mechanism of progesterone-induced permissivity in the upperfemale reproductive tract$472,500
R01 · FY2020 · AI · contact PI
Project 1: Using CyTOF to identify phenotypic and functional biomarkers predicting time to HIV rebound after treatment interruption$320,188
P01 · FY2020 · AI · contact PI
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologies$540,392
R01 · FY2019 · AI · contact PI
Elucidating the mechanism of progesterone-induced permissivity in the upper female reproductive tract$396,250
R01 · FY2019 · AI · contact PI
Project 1: Using CyTOF to identify phenotypic and functional biomarkers predicting time to HIV rebound after treatment interruption$319,332
P01 · FY2019 · AI · contact PI
Elucidating the mechanism of progesterone-induced permissivity in the upper female reproductive tract$396,250
R01 · FY2018 · AI · contact PI
Project 1: Using CyTOF to identify phenotypic and functional biomarkers predicting time to HIV rebound after treatment interruption$324,878
P01 · FY2018 · AI · contact PI
Project 1: Using CyTOF to identify phenotypic and functional biomarkers predicting time to HIV rebound after treatment interruption$430,155
P01 · FY2017 · AI · contact PI
Elucidating the mechanism of progesterone-induced permissivity in the upper female reproductive tract$396,250
R01 · FY2017 · AI · contact PI
Characterization of Exosomes From Semen of Uninfected and HIV-Infected Men$198,019
R21 · FY2017 · AI · contact PI
Elucidating the mechanism of progesterone-induced permissivity in the upper female reproductive tract$396,250
R01 · FY2016 · AI · contact PI
Characterization of Exosomes From Semen of Uninfected and HIV-Infected Men$252,250
R21 · FY2016 · AI · contact PI
Exploring the Role of Semen Amyloids in Promoting HIV Infection and Fertilization$243,559
R00 · FY2016 · AI · contact PI
Characterization of Gallic Acid as a Novel HIV Microbicide Candidate$198,125
R21 · FY2016 · AI · contact PI
Exploring the Role of Semen Amyloids in Promoting HIV Infection and Fertilization$249,000
R00 · FY2015 · AI · contact PI
Characterization of Gallic Acid as a Novel HIV Microbicide Candidate$237,750
R21 · FY2015 · AI · contact PI
Exploring the Role of Semen Amyloids in Promoting HIV Infection and Fertilization$132,705
K99 · FY2013 · AI · contact PI